Literature DB >> 11520084

Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla.

G Cserni1.   

Abstract

BACKGROUND: Histopathological factors may help identifying a subgroup of breast cancer patients with metastases confined to the sentinel lymph nodes (SLNs).
METHODS: A retrospective analysis was carried out on 111 tumours successfully mapped with Patent blue, 69 of which had SLN metastases.
RESULTS: Multivariate analysis revealed that SLN metastases situated in the sinuses and a small tumour size are the two most important predictors of involvement of only one SLN. The metastasis size and a small tumour size were found important in the model discriminating between tumours with metastases to SLNs only and those with non-SLN involvement. Classification of tumours with only one SLN metastasis and those with a multinodal involvement resulted in a smaller error rate, falsely classified as lesser nodal involvement. Patients with tumours <1.8 cm and metastatic to the sinuses of a single SLN had a low probability of non-SLN metastasis, and might be candidates for axillary sparing after a positive SLN biopsy.
CONCLUSIONS: Further investigations are required to assess the validity of such predictive models for the identification of patients with no metastases beyond the SLN. Axillary treatment must remain the rule until predictive models of non-SLN involvement are fully validated. Copyright 2001 Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2001        PMID: 11520084     DOI: 10.1053/ejso.2001.1138

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

Review 1.  Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy.

Authors:  Giuseppe Viale; Eugenio Maiorano; Giancarlo Pruneri; Mauro G Mastropasqua; Stefano Valentini; Viviana Galimberti; Stefano Zurrida; Patrick Maisonneuve; Giovanni Paganelli; Giovanni Mazzarol
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  Comparison of two models for predicting non-sentinel lymph node metastases in sentinel lymph node-positive breast cancer patients.

Authors:  Giovanni D'Eredita'; Vito Leopoldo Troilo; Fernando Fischetti; Giuseppe Rubini; Tommaso Berardi
Journal:  Updates Surg       Date:  2011-05-31

4.  Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology.

Authors:  G Cserni; I Amendoeira; N Apostolikas; J P Bellocq; S Bianchi; W Boecker; B Borisch; C E Connolly; T Decker; P Dervan; M Drijkoningen; I O Ellis; C W Elston; V Eusebi; D Faverly; P Heikkila; R Holland; H Kerner; J Kulka; J Jacquemier; M Lacerda; J Martinez-Penuela; C De Miguel; J L Peterse; F Rank; P Regitnig; A Reiner; A Sapino; B Sigal-Zafrani; A M Tanous; S Thorstenson; E Zozaya; G Fejes; C A Wells
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

5.  The microanatomic location of metastatic breast cancer in sentinel lymph nodes predicts nonsentinel lymph node involvement.

Authors:  Carolien H M van Deurzen; Cees A Seldenrijk; Ron Koelemij; Richard van Hillegersberg; Monique G G Hobbelink; Paul J van Diest
Journal:  Ann Surg Oncol       Date:  2008-02-06       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.